Jason Duncan, Chief Legal Officer and GC at ALBIREO PHARMA, INC. (ALBO), sold 656 shares at $19.58 ($13K) on 2022-10-24, disclosed to the SEC on 2022-10-25.
Scheduled sale ($13k) by Chief Legal Officer and GC under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.40 | 456 | $9K | 69.3% |
| 2 | $19.54 | 96 | $2K | 14.7% |
| 3 | $19.58 | 104 | $2K | 16.0% |
| Total | $19.45 avg | 656 | $13K | 100% |
| Filing → |
| ALBO | SELL | 2022-07-25 | $16K | — | Filing → |
| ALBO | SELL | 2022-04-25 | $22K | — | Filing → |
| ALBO | SELL | 2022-01-25 | $42K | — | Filing → |